Market Capitalization (Millions $) |
4,513 |
Shares
Outstanding (Millions) |
420 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-1 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Corner Growth Acquisition Corp
PolarityTE™ is a commercial-stage biotechnology and regenerative biomaterials
company focused on transforming the lives of patients by discovering, designing
and developing a range of regenerative tissue products and biomaterials for the
fields of medicine, biomedical engineering and material sciences. We believe that
our PolarityTE platform technology is a new approach to pragmatic and functional
tissue regeneration that has the potential to address many of the challenges currently
facing the regenerative medicine and cell therapy markets. Recognizing the natural
complexity of human tissue, our core “TE” platform begins with a small
piece of the patient’s own, or autologous, healthy tissue, rather than artificially
manipulated individual cells. From this small piece of healthy autologous tissue,
we create an easily deployable, dynamic and self-propagating product designed
to enhance and stimulate the patient’s own cells to regenerate the target
tissues. Rather than manufacturing with synthetic and foreign materials within
artificially engineered environments, we manufacture with the patient’s
own tissue and use the patient’s own body to support the regenerative process
to create the same tissue from which it was derived. We believe that our innovative
method promotes and accelerates growth of the patient’s tissues to undergo
a form of effective regenerative healing.
Company Address: 251 Lytton Avenue Palo Alto 94301 CA
Company Phone Number: 543-8180 Stock Exchange / Ticker: NASDAQ COOL
COOL is expected to report next financial results on March 30, 2024. |
|
|